Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Vanhove

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
International Journal of Oral and Maxillofacial Surgery|July 23, 1999
Zygomatico-coronoid ankylosis: a case reportF Vanhove, M Dom
Acta Stomatologica Belgica|June 1, 1997
Fracture of the coronoid process: report of a caseF Vanhove, M Dom, G Wackens
Pain Medicine (Malden, Mass.)|July 5, 2012
Early pain reduction can predict treatment response: results of integrated efficacy analyses of a once-daily gastroretentive formulation of gabapentin in patients with postherpetic neuralgiaMark P Jensen, Ping H Hsu, Geertrui F Vanhove
The Clinical Journal of Pain|March 1, 2013
NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label studyDavid M Simpson, Stephen Brown, Jeffrey K Tobias, et al.
Pain Medicine (Malden, Mass.)|February 2, 2010
NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extensionMisha Miroslav Backonja, T Philip Malan, Geertrui F Vanhove, et al.
BMC Neurology|October 13, 2010
Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgiaLynn R Webster, Marvin Tark, Richard Rauck, et al.
Journal of Pain and Symptom Management|November 15, 2012
Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studiesRichard L Rauck, Gordon A Irving, Mark S Wallace, et al.
The Clinical Journal of Pain|February 2, 2013
Long-term safety of gastroretentive gabapentin in postherpetic neuralgia patientsMark P Jensen, Gordon Irving, Richard Rauck, et al.
Journal of Pain Research|February 14, 2012
Tolerability of NGX-4010, a capsaicin 8% patch, in conjunction with three topical anesthetic formulations for the treatment of neuropathic painLynn R Webster, John F Peppin, Frederick T Murphy, et al.
Journal of Adolescent and Young Adult Oncology|October 26, 2016
Risk-Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young AdultsGregory F Guzauskas, Kathleen F Villa, Geertrui F Vanhove, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
International Journal of Oral and Maxillofacial Surgery|July 23, 1999
Zygomatico-coronoid ankylosis: a case reportF Vanhove, M Dom
Acta Stomatologica Belgica|June 1, 1997
Fracture of the coronoid process: report of a caseF Vanhove, M Dom, G Wackens
Pain Medicine (Malden, Mass.)|July 5, 2012
Early pain reduction can predict treatment response: results of integrated efficacy analyses of a once-daily gastroretentive formulation of gabapentin in patients with postherpetic neuralgiaMark P Jensen, Ping H Hsu, Geertrui F Vanhove
The Clinical Journal of Pain|March 1, 2013
NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label studyDavid M Simpson, Stephen Brown, Jeffrey K Tobias, et al.
Pain Medicine (Malden, Mass.)|February 2, 2010
NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled study with an open-label extensionMisha Miroslav Backonja, T Philip Malan, Geertrui F Vanhove, et al.
BMC Neurology|October 13, 2010
Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgiaLynn R Webster, Marvin Tark, Richard Rauck, et al.
Journal of Pain and Symptom Management|November 15, 2012
Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studiesRichard L Rauck, Gordon A Irving, Mark S Wallace, et al.
The Clinical Journal of Pain|February 2, 2013
Long-term safety of gastroretentive gabapentin in postherpetic neuralgia patientsMark P Jensen, Gordon Irving, Richard Rauck, et al.
Journal of Pain Research|February 14, 2012
Tolerability of NGX-4010, a capsaicin 8% patch, in conjunction with three topical anesthetic formulations for the treatment of neuropathic painLynn R Webster, John F Peppin, Frederick T Murphy, et al.
Journal of Adolescent and Young Adult Oncology|October 26, 2016
Risk-Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young AdultsGregory F Guzauskas, Kathleen F Villa, Geertrui F Vanhove, et al.
Pageof 4